United States · FDA National Drug Code directory
LEVOPHED(R) NOREPINEPHRINE BITARTRATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1315_ba9ee8b4-ee9c-3d1b-e053-2995a90a11de
- Product NDC
- 51662-1315
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- LEVOPHED(R) NOREPINEPHRINE BITARTRATE
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- NDA
- Marketing start / end (source format)
- 20181018
- Source listing expiry
- 20261231
Source-listed ingredients
- NOREPINEPHRINE BITARTRATE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 4 mL in 1 VIAL, SINGLE-DOSE (51662-1315-1) · 51662-1315-1
- 10 POUCH in 1 CASE (51662-1315-3) / 1 mL in 1 POUCH (51662-1315-2) · 51662-1315-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →